GrowGeneration GRWG Stock Downside Risk Overview Q4 2025 EPS Misses Views PRI Primerica reports 69 EPS beat for Q4 2025 stock slips 03 in todays trading Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today Defi Tech DEFT Stock Is It in Consolidation Phase Q4 2025 Earnings Beat Estimates